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Abstract
Background: In patients with malaria mixed species infections are common and under reported. In PCR studies
conducted in Asia mixed infection rates often exceed 20%. In South-East Asia, approximately one third of patients
treated for falciparum malaria experience a subsequent Plasmodium vivax infection with a time interval suggesting
relapse. It is uncertain whether the two infections are acquired simultaneously or separately. To determine whether
mixed species infections in humans are derived from mainly from simultaneous or separate mosquito inoculations
the literature on malaria species infection in wild captured anopheline mosquitoes was reviewed.
Methods: The biomedical literature was searched for studies of malaria infection and species identification in
trapped wild mosquitoes and artificially infected mosquitoes. The study location and year, collection methods,
mosquito species, number of specimens, parasite stage examined (oocysts or sporozoites), and the methods of
parasite detection and speciation were tabulated. The entomological results in South East Asia were compared
with mixed infection rates documented in patients in clinical studies.
Results: In total 63 studies were identified. Individual anopheline mosquitoes were examined for different malaria
species in 28 of these. There were 14 studies from Africa; four with species evaluations in individual captured
mosquitoes (SEICM). One study, from Ghana, identified a single mixed infection. No mixed infections were
identified in Central and South America (seven studies, two SEICM). 42 studies were conducted in Asia and
Oceania (11 from Thailand; 27 SEICM). The proportion of anophelines infected with Plasmodium falciparum
parasites only was 0.51% (95% CI: 0.44 to 0.57%), for P. vivax only was 0.26% (95% CI: 0.21 to 0.30%), and for mixed
P. falciparum and P. vivax infections was 0.036% (95% CI: 0.016 to 0.056%). The proportion of mixed infections in
mosquitoes was significantly higher than expected by chance (P < 0.001), but was one fifth of that sufficient to
explain the high rates of clinical mixed infections by simultaneous inoculation.
Conclusions: There are relatively few data on mixed infection rates in mosquitoes from Africa. Mixed species
malaria infections may be acquired by simultaneous inoculation of sporozoites from multiply infected anopheline
mosquitoes but this is relatively unusual. In South East Asia, where P. vivax infection follows P. falciparum malaria in
one third of cases, the available entomological information suggests that the majority of these mixed species
malaria infections are acquired from separate inoculations.
Background
Where transmission of both vivax and falciparum malaria
is high in parts of Oceania, mixed species infections in
humans are common. With frequent infection from
repeated inoculation it is not surprising that infections
accumulate and so comprise a multiplicity of genotypes
and species. In South-East Asia where transmission of
malaria is low, seasonal, and unstable people typically
receive one infected mosquito bite each year or less, yet a
remarkably high proportion (30 to 50%) of acute Plasmo-
dium falciparum malaria infections are followed soon
afterwards by an infection with Plasmodium vivax.
Indeed in endemic areas in this region, the main clinical
complication of falciparum malaria is subsequent vivax
malaria, far outweighing the incidence of recrudescent
falciparum malaria [1-5]. The intervals between presenta-
tion with falciparum malaria and the subsequent vivax
episode are very similar to the intervals between acute
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any medium, provided the original work is properly cited.vivax malaria and the first relapse [2,5]. This suggests
that the vivax malaria episode, which follows falciparum
malaria, also results from a relapse. The very high rate of
co-infection in South-East Asia has suggested that the
two infections are acquired together despite the low
transmission frequency.
Mixed species infections in patients are often under
reported, with a tendency to over report the more danger-
ous P. falciparum. In endemic areas, where the prevalence
of malaria revealed by sensitive PCR methods is much
higher than evident from microscopy, high rates of mixed
blood stage infection (~20%) have been reported, presum-
ably because both infections are carried chronically [6,7].
Lower rates of mixed species infection occur in sympto-
matic non-immunes presenting with acute falciparum
malaria in low transmission settings. Even with sensitive
PCR detection of low parasitaemia, the proportion of
mixed infections detected does not approach the 30 to
50% required to explain the proportion of vivax malaria
episodes, which follow P. falciparum malaria in these
same patients. Simultaneous infection studies in the
malaria therapy of neurosyphilis and in volunteers clearly
showed that mixed infection could occur from simulta-
neous inoculation, that pre-erythrocytic development of
P. falciparum was more rapid, and that in the blood stage
infection P. falciparum tended to suppress P. vivax,s ol o w
level P. vivax parasitaemia might still be missed by current
diagnostic methods [8-10]. Plasmodium vivax may also
suppress P. falciparum; up to 10% of acute vivax malaria
episodes in Thailand are followed shortly after by P. falci-
parum infections without reinfection [3,11]. Blood stage
infections in which both parasites are detectable could
either derive from simultaneous inoculation of the sporo-
zoites of the two species from a doubly infected anophe-
line mosquito, or a recently acquired infection of one
species might supervene a chronic infection with the
other. As transmission intensities in most of South East
Asia are very low (EIRs typically < 1/year) the probabilities
of separate inoculations within a narrow time window are
extremely low [12]. To resolve these questions and under-
stand better the epidemiology of mixed species infection
in different transmission settings we examined the pub-
lished literature on immunological and molecular parasite
species identification in anopheline vectors in malaria
endemic areas.
Methods
The NLM PubMed was searched since 1987 for publica-
tions in English describing studies on anopheline vectors
in malaria endemic areas in which malaria parasite iden-
tification had been performed using immunological or
molecular methods. The search terms were; anopheles
AND sporozoite OR oocyst; Subheadings: Asia OR Africa
OR America. Studies of both trapped wild mosquitoes
and artificially infected mosquitoes were included. After
compilation the lists were checked manually. The loca-
tion of study and year, the collection method, mosquito
species, number of specimens, parasite stage examined
(oocysts or sporozoites), parasite detection method, and
the results of the species identification were tabulated.
Investigators in the South East Asian region were con-
tacted for further information. ELISA and more recently
PCR methods were used generally for species identifica-
tion. The sensitivity of these different methods were also
reviewed.
Results
In total, 42 studies were identified which were conducted
in Asia and Oceania (11 were from Thailand) and 21 stu-
dies were conducted in other areas (14 were from Africa
and 7 from Central or South America) between 1987 and
2011. Three of the American and three of the Asian stu-
dies involved blood feeding of anophelines and later dis-
section. In the remainder of the studies trapped wild
anophelines were examined.
Sensitivity of different methods used for parasite
identification
Table 1 shows the different methods used to identify
mixed infections and, where quoted, their respective
sensitivities and limits of detection.
Entomological studies from Asia and Oceania (Table 2,
and 3)
In four studies, sporozoites were examined but not spe-
ciated; 525 of 85,359 mosquitoes were positive. In ten stu-
dies some or all of the anophelines caught were pooled in
groups before analysis. In these ten studies 155,497 ano-
phelines were examined for P. falciparum and 184,744
were examined for P. vivax.O n l yo n es t u d yr e p o r t e d
mixed infections but, because of pooling, it cannot be
ascertained whether this was in single mosquitoes. In 27
studies of trapped wild mosquitoes 167,465 individual
anophelines were examined for P. falciparum sporozoites
and in a further 2,049 the whole body was assessed. P. fal-
ciparum p a r a s i t e so n l yw e r ei d e n t i f i e di n1 0 8 7( 0 . 5 1 % ;
95% CI: 0.44 to 0.57%). For P. vivax 334,698 anophelines
were assessed and 544 were positive (0.25%%; 95% CI: 0.21
to 0.30%) for P. vivax alone. Mixed P. falciparum and P.
vivax infections were assessed in 41,325 mosquitoes. If
there was no association between the parasites then none
of these would have been expected to have mixed species
infection, whereas 17 (0.036%: 95% CI: 0.016 to 0.056%)
had evidence of infection with both parasites (p < 0.001)
(Figure 1). In studies conducted in Thailand, where most
of the clinical trial information on mixed species infections
has come from, 11,289 anophelines were examined in
published studies and 23 P. falciparum (0.20%) and 24
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9P. vivax (0.21%) infections, but no mixed P. falciparum
and P. vivax infections were found (Figure 1). Plasmodium
malariae was found in 97 of 143,261 anophelines exam-
ined (0.051%), one of which was also infected with P. falci-
parum.O n l yo n eo ft h eP. malariae was from mainland
SE Asia. One mixed P. falciparum, P. vivax and Plasmo-
dium knowlesi infection was identified in Vietnam. No
Plasmodium ovale was identified. The VK210 and 247 P.
vivax genotypes were distinguished in most studies; there
were 207 VK210 and 279 VK247, and six were mixed
Table 3 Studies from Asia
References Countries No. with positive oocysts No. with positive whole mosquitoes
PF Total PV Total PF
+PV
Total PF Total PV Total PV-
VK210
Total PV-
VK247
Total PF
+PV
Total VK210
+VK247
Total
ASIA
Toma T
2002 [41]
Khammouane,
Lao
1 10 1 391
Alam et al.,
2010 [55]
Bangladesh 8 302 7 306 1 7
Trung et
al., 2004
[56]
Vietnam,
Cambodia
14 892 1 28 2 361 2 550
Tangin et
al., 2008
[34]
Bangladesh 12 669 1 669 6 669
Swain et
al.,2009
[57]
Orissa, India 2 186
Total 0 0 1 10 1 391 36 2049 1 669 8 334 3 368 6 669 2 550
Figure 1 Left side: Pie charts showing the proportion of individual anopheline vector mosquitoes examined which were positive for P.
falciparum, P. vivax or both malaria parasite species in entomological studies conducted in Asia and Oceania (top) and in the
subgroup of studies conducted in Thailand (bottom). On the right side are pie charts showing the proportion of malaria patients in Thailand
with P. falciparum, P. vivax or both malaria parasite species concurrently assessed by PCR typing of blood samples (top). The proportion of
patients in Thailand who have P. vivax infections following P. falciparum (without the possibility of reinfection) within a nine week period are
shown below.
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Page 6 of 12genotype infections. None of the four artificial feeding stu-
dies in which different vectors were fed on parasitaemic
blood yielded any mixed infections despite high rates of
positivity for the individual parasite species.
Comparison of mixed species infection rates in patients
and in the mosquito vectors in Asia and Oceania
Studies conducted on the treatment of falciparum
malaria during and immediately after the first world war
indicated that vivax malaria commonly followed falci-
parum malaria acquired in Europe or Asia. In India
rates ranged from seven to 40% [13]. Between March
1924 and July 1925 Sinton compared two different qui-
nine regimens in the treatment of falciparum malaria in
British soldiers [13]. They were followed for eight weeks
at Kasauli (above the level of malaria transmission at an
altitude of 6,000 feet in Himachal Pradesh). Of 76 sol-
diers completing follow-up 30 (39%) had subsequent
vivax malaria. More recent information has come mainly
from South-East Asia. In 1987, Looareesuwan et al [1]
reported that of 320 adult patients treated in the Bang-
kok Hospital for Tropical Diseases and followed in hos-
pital so that reinfection could be excluded definitely,
104 (32%) had a subsequent recurrence of vivax within
two months. The relapse rate for vivax malaria in the
same institution was 50% (200/400) [14].
Douglas et al [4] recently reviewed treatment
responses in 10,549 patients (4,960 children aged < 15
years and 5,589 adults) treated for falciparum malaria in
a malaria endemic area on the NorthWest border of
Thailand. Reinfection could not be excluded. Of these
patients, 9,385 (89.0%) had P. falciparum monoinfection
and 1,164 (11.0%) had mixed P. falciparum/P. vivax
infections according to microscopy at presentation. The
cumulative proportion with P. vivax recurrence by day
63 was very similar to that documented in Bangkok;
3 1 . 5 %( 9 5 %C I ,3 0 . 1 %t o3 3 . 0 % ) .H o w e v e rt h eo v e r a l l
rate of P. vivax infection following P. falciparum mono-
infection may have been underestimated as the cumula-
tive risk of vivax malaria was 51.1% (95% CI, 46.1% to
56.2%) after treatment with rapidly eliminated drugs (t1/
2,1 day), 35.3% (95% CI, 31.8% to 39.0%) after treatment
with intermediate half-life drugs (t1/2 1 to 7 days), and
19.6% (95% CI, 18.1% to 21.3%) after treatment with
slowly eliminated drugs (t1/2 > 7 days). Some late
relapses suppressed by the slowly eliminated drugs may
therefore have emerged after day 63. The cumulative 63
day relapse/recurrence rate for vivax malaria at the
same location was 63% (143/227)[15]. Two entomologi-
cal evaluations were performed in this location. Of 596
anopheline vectors (Anopheles dirus, Anopheles mini-
mus, Anopheles maculatus) examined individually five
carried P. vivax and two carried P. falciparum.T h e r e
were no mixed infections (McGready R: personal
communication).
Smithuis et al [5] recently studied therapeutic
responses to different ACT regimens in Myanmar in
808 adults and children with acute falciparum malaria
or mixed species infections (16%). 330 (41%) patients
had one or more episodes of P. vivax infection during
follow-up. Of the 679 patients with P. falciparum infec-
tions only, 235 (35%) had subsequent P. vivax malaria.
Children were nearly three times more likely to develop
intercurrent vivax malaria than adults.
T a k i n gt h em o r ec o n s e r v a t i v ed a t af r o mB a n g k o ki n
Thailand where reinfection could be excluded, then if all
vivax infections are acquired from simultaneous inocula-
tion it would be expected that the mixed falciparum and
vivax infection proportion in mosquitoes would be 32%
of all the P. falciparum infected mosquitoes
i.e. 0.32 =

Mixed Pf + Pv

/

P. falciparum +

Mixed Pf + Pv

In fact no mixed species infections were recorded in
Thailand among 23 P. falciparum positive mosquitoes
(Figure 1), whereas seven or eight would have been
expected if all mixed species infections had been
acquired by simultaneous inoculation (p = 0.01). Overall
in Asia and Oceania only 6.6% of the P. falciparum
infected mosquitoes also carried P. vivax, a proportion
that is considerably lower than expected from the clini-
cal data.
Entomological studies from Central and South America
(Table 4)
In five of the seven studies identified some or all the
mosquitoes were pooled before analysis and in three
studies anopheline mosquitoes were infected artificially.
One of these studies examined only for P. vivax.N o n e
of these studies detected mixed infections despite esti-
mated infection rates in the pooled mosquitoes ranging
from 0.1 to 3.2% for P. vivax and 0 to 0.87% for P. falci-
parum. In the two studies in which individual anophe-
lines were examined (one from Columbia, the other
from Brazil) 7,125 individual anophelines were exam-
ined. P. falciparum sporozoites only were identified in 3
(0.042%), P. malariae in 1 (0.014%), and 50 were posi-
tive (0.70%) for P. vivax a l o n e( 4 7P vV K2 1 0a n d3P v
V K2 4 7 ) .N om i x e dP. falciparum and P. vivax infec-
tions were identified.
Entomological studies from Africa (Table 4)
In one of the 14 studies identified mosquitoes were arti-
ficially infected and in two studies mosquitoes were
pooled before analysis. Eight studies examined the mos-
quitoes only for P. falciparum. In the artificial feeding
study conducted in Guinea-Bissau where all species
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Page 8 of 12were investigated 510 anophelines were examined and
infection rates with single species ranged from 5 to 15%
for P. falciparum, 1 to 2% for P. malariae and 0.54 to
5% for P. ovale. Mixed infection rates ranged from 0.4
to 15%. In the 11 studies in which individual anophe-
lines were examined 1654 of 27738 (6%) had P. falci-
parum sporozoites although rates for individual vectors
in different studies varied between 0.7% and 78%. In the
four studies where mixed infections were studied speci-
fically, two studies examined only for P. vivax.I nt h e
remaining two studies one from Cameroon did not
identify mixed infections. In the other study from
Ghana overall infectivity rate was 7.7% for Anopheles
gambiae (s.s) and 4.9% for Anopheles funestus.O ft h e
sporozoite positive mosquitoes 5.7% contained P. malar-
iae only and 5.7% contained P. ovale only and a single
A. gambiae (s.s) was identified carrying mixed P. falci-
parum and P. malariae. The remainder were positive
for P. falciparum only. No mixed P. falciparum and P.
vivax infections were identified. P. vivax was reported
only from Ethiopia where 14 (1.8%) of 796 mosquitoes
were positive for P. vivax and 4 (0.5%) were positive for
P. falciparum. No mixed infections were identified in
this study.
Discussion
In areas where malaria transmission is stable and
intense the majority of the human population is con-
stantly infected, although older children and adults
often have parasite densities below the level of micro-
scopy detection. Many parts of Africa have this pattern
of malaria transmission. Mixed genotype P. falciparum
infections are common, but there are relatively few stu-
dies which have examined the prevalence of other infec-
tions. In Asia and Oceania, these areas of intense
transmission tend to be very small focal forest or forest
fringe areas, and much of the coastal part of the Island
of New Guinea. In those areas where both P. falciparum
and P. vivax are prevalent mixed species infections with
both species are common but maybe also be below the
level of microscopy detection [8]. Both infections coexist
chronically [16]. Sensitive PCR methods reveal high
rates of mixed species infection (~20%) [6] although it
seems likely that the majority of mixed infections in
humans are acquired from separate mosquito inocula-
tions. Asymptomatic or oligosymptomatic individuals
who are parasitaemic have declared themselves able to
control the infections and so are much more likely to
have a multiplicity of different genotypes present (albeit
at low densities) and also mixed species infections.
In contrast in much of the remainder of Asia trans-
mission is generally low and seasonal and, although P.
vivax infections may still be asymptomatic, P. falci-
parum malaria is usually accompanied by illness and
treatment seeking. Symptomatic infections are seen at
all ages, although the burden of symptomatic vivax
malaria is in young children. In this epidemiological
context mixed species infections are found in 10% or
less of acute infections, yet approximately one third of
patients still experience vivax malaria following falci-
parum malaria. The high efficacy of initial falciparum
malaria treatment against P. vivax and the time interval
between initial presentation and the subsequent vivax
malaria episode suggests that it is a relapse. This pre-
sumed relapse was thought to result from simulta-
neously acquired mixed species infection, but the
evidence reviewed here does not support this hypothesis.
The proportion of P. falciparum infected mosquitoes
overall which also carried P. vivax in Asia and Oceania
was only 6.6% overall. As expected most mixed infec-
tions in mosquitoes were found in studies on the island
of New Guinea where transmission of both species is
intense. None were found in Thailand where one third
of P. falciparum malaria is followed by P. vivax. Thus,
the proportion of mixed infections in anopheline mos-
quito vectors in Asia and Oceania is approximately one
fifth of that expected. These findings suggest that simul-
taneous inoculation of the two malaria species does
occur, and indeed is more frequent than would be
expected by chance alone, but that the majority of
mixed species infections do not derive from a single
mosquito bite.
Several explanations are possible. The entomology
sampling frameworks in these studies may not have
been representative. The vectors might not have been
adequately representative of those transmitting malaria.
The laboratory methods may have been insensitive
(Table 1) or not designed specifically to identify mixed
species infections. These concerns were addressed to
some extent in those studies in which some mixed
infections were identified. Lack of sensitivity seems an
unlikely explanation for the observations. As only a
small fraction of the salivary gland sporozoites are
inoculated by a biting anopheline mosquito- it seems
unlikely that these would derive from very small subpo-
pulations of different species sporozoites which were
below the level of antigen or PCR detection.
If the mixed species infections are all acquired from
simultaneous inoculation it would also requires very
high rates of concomitant P. falciparum and P. vivax
gametocyte carriage at infectious densities in the blood
of the parasitaemic population. This may well occur in
high transmission settings but is rare in low unstable
transmission settings and is not supported by the mos-
quito feeding studies reported here. As P. vivax develops
more rapidly than P. falciparum in the anopheline vec-
tor, it also demands mosquito longevity. If the two
infections were acquired separately then the close and
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Page 9 of 12reproducible temporal association between the infec-
tions needs explanation. Although the distribution of
infected mosquito biting undoubtedly clusters it would
require a remarkable degree of association for one third
of all P. falciparum inoculations to be accompanied
within a day or two by a P. vivax inoculation -when
average inoculation rates are less than one infected bite
per person per year! Nevertheless mixed species infec-
tions in anopheline mosquitoes do occur in Asia signifi-
cantly more frequently than expected by chance so it is
clear that simultaneous transmission does occur and
does contribute to mixed infections. It is likely to
account for the significant proportion of acute sympto-
matic malaria in low transmission settings where both
species are identified in the blood at presentation.
The data from Central and South America where
transmission is generally low and unstable also showed
low rates of mosquito infection. No mixed infections
were found but as P. falciparum and P. malariae infec-
tion rates were also very low this negative finding has
limited significance. There are surprisingly few data
from Africa on species other than P. falciparum. Plas-
modium vivax was identified in Ethiopia as expected. In
Ghana where transmission is intense mixed infection
was identified. Artificial infection studies in Guinea-Bis-
sau suggested that mixed infection of mosquitoes would
be frequent, but these data are too few to draw firm
conclusions on the entomology of mixed malaria infec-
tion in Africa.
This review is almost certainly an underestimate of
the available information. For example, much of the
Central and South American literature is in Spanish or
Portuguese and some of the African literature is in
French. The search strategy employed may well have
missed studies in English, which lacked the key words.
Nevertheless because of the large apparent discrepancies
between mixed species infection rates in the anopheline
mosquito vectors and humans this comprehensive sam-
ple of the literature provides a convincing message.
Mixed infections of anopheline vectors do occur and
account for some of the mixed infections in humans.
However in South East Asia where P. vivax infections
follows P. falciparum malaria in one third of cases, the
published data suggests that the majority of these mixed
infections are not acquired by simultaneous inoculation.
A more plausible explanation is that P. vivax relapse is
stimulated by symptomatic falciparum malaria infection.
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